Science News
from research organizations

Vitamin D supplementation does not reduce rate or severity of colds, study suggests

Date:
October 2, 2012
Source:
American Medical Association (AMA)
Summary:
Although some data have suggested a possible inverse association between serum vitamin D levels and the incidence of upper respiratory tract infections (colds), participants in a randomized controlled trial who received a monthly dose of 100,000 IUs of vitamin D3 did not have a significantly reduced incidence or severity of colds.
Share:
       
FULL STORY

Although some data have suggested a possible inverse association between serum vitamin D levels and the incidence of upper respiratory tract infections (colds), participants in a randomized controlled trial who received a monthly dose of 100,000 IUs of vitamin D3 did not have a significantly reduced incidence or severity of colds, according to a study in the October 3 issue of JAMA.

The association of vitamin D insufficiency and susceptibility to viral respiratory tract infections has been unclear, according to background information in the article.

David R. Murdoch, M.D., of the University of Otago, Christchurch, New Zealand, and colleagues conducted a randomized trial to examine the effect of vitamin D supplementation on incidence and severity of upper respiratory tract infections (URTIs) in healthy adults. The study, conducted between February 2010 and November 2011, included 322 healthy adults in New Zealand. Participants were randomly assigned to receive an initial dose of 200,000 IU oral vitamin D3, then 200,000 IU one month later, then 100,000 IU monthly (n = 161), or placebo administered in an identical dosing regimen (n = 161), for a total of 18 months.

The average 25-hydroxyvitamin D (25-OHD) level of participants at the beginning of the study was 29 ng/mL. Vitamin D supplementation resulted in an increase in serum 25-OHD levels that was maintained at greater than 48 ng/mL throughout the study. There were 593 URTI episodes in the vitamin D group and 611 in the placebo group.

The researchers found that there was no statistically significant differences in the number of URTIs per participant (average, 3.7 per person in the vitamin D group and 3.8 per person in the placebo group), duration of symptoms per episode (average, 12 days in each group), number of days of missed work as a result of URTIs, or severity of URTI episodes.

"The main finding from this study is that a monthly dose of 100,000 IU of vitamin D3 in healthy adults did not significantly reduce the incidence or severity of URTIs. This result remained unchanged when the analysis included winter season or baseline 25-OHD levels," the authors write. "Further research is required to clarify whether there is benefit from supplementation in other populations and with other dosing regimens."


Story Source:

The above post is reprinted from materials provided by American Medical Association (AMA). Note: Materials may be edited for content and length.


Journal Reference:

  1. David R. Murdoch et al. Effect of Vitamin D3 Supplementation on Upper Respiratory Tract Infections in Healthy AdultsThe VIDARIS Randomized Controlled TrialVitamin D3 and Upper Respiratory Tract Infections. JAMA: The Journal of the American Medical Association, 2012; 308 (13): 1333 DOI: 10.1001/jama.2012.12505

Cite This Page:

American Medical Association (AMA). "Vitamin D supplementation does not reduce rate or severity of colds, study suggests." ScienceDaily. ScienceDaily, 2 October 2012. <www.sciencedaily.com/releases/2012/10/121002161751.htm>.
American Medical Association (AMA). (2012, October 2). Vitamin D supplementation does not reduce rate or severity of colds, study suggests. ScienceDaily. Retrieved August 2, 2015 from www.sciencedaily.com/releases/2012/10/121002161751.htm
American Medical Association (AMA). "Vitamin D supplementation does not reduce rate or severity of colds, study suggests." ScienceDaily. www.sciencedaily.com/releases/2012/10/121002161751.htm (accessed August 2, 2015).

Share This Page: